Mechanisms of Disease: transcription factors in inflammatory arthritis
Authors:
- 1 August 2006
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Rheumatology
- Vol. 2 (8) , 434-442
Abstract
There is increasing interest in the role of transcription factors in the pathogenesis of inflammatory arthritis. Biologic and genetic studies are adding to current knowledge, and revealing potential targets for anti-inflammatory therapies that aim to modulate transcription factor activity. Studies on the pathogenesis of inflammatory arthritides have begun to delve into the molecular and cellular mechanisms behind the development of these diseases, and transcription factors, as key regulators of immune-effector-cell development and function, have received growing attention. Their involvement in immune cells, such as T and B lymphocytes, macrophages and neutrophils, and cells from diseased tissues, such as synoviocytes, has been investigated, revealing dominant roles for members of the nuclear factor κB family, signal-transducer and activator of transcription family, and activator protein 1 family. This review summarizes recent findings and current knowledge regarding the roles of transcription factors in inflammatory arthritis, as evidenced by both biological and genetic studies, and discusses the relevance of these findings for anti-inflammatory therapies.Keywords
This publication has 58 references indexed in Scilit:
- NFAT proteins: key regulators of T-cell development and functionNature Reviews Immunology, 2005
- The Met-196 → Arg Variation of Human Tumor Necrosis Factor Receptor 2 (TNFR2) Affects TNF-α-induced Apoptosis by Impaired NF-κB Signaling and Target Gene ExpressionJournal of Biological Chemistry, 2005
- CTLA-4–Ig Activates Forkhead Transcription Factors and Protects Dendritic Cells from Oxidative Stress in Nonobese Diabetic MiceJournal of Experimental Medicine, 2004
- Regulation of the symmetry and intensity of immune complex–mediated synovitis by nuclear factor of activated T cellsArthritis & Rheumatism, 2004
- Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα TherapyJournal of Experimental Medicine, 2004
- CD152 (CTLA-4) Determines the Unequal Resistance of Th1 and Th2 Cells against Activation-induced Cell Death by a Mechanism Requiring PI3 Kinase FunctionJournal of Experimental Medicine, 2004
- Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritisRheumatology, 2003
- RANKL and RANK as novel therapeutic targets for arthritisCurrent Opinion in Rheumatology, 2003
- AP-1 as a regulator of cell life and deathNature Cell Biology, 2002
- CTLA4 ligation attenuates AP-1, NFAT and NF-κB activity in activated T cellsEuropean Journal of Immunology, 1999